Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

Εμφάνιση άλλων εκδόσεων (1)

OBJECTIVES: This study sought to explore the potential role of noncontrast myocardial T1 mapping for detection of cardiac involvement in patients with primary amyloid light-chain (AL) amyloidosis. BACKGROUND: Cardiac involvement carries a poor prognosis in systemic AL amyloidosis. Late gadolinium en...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Karamitsos, T, Piechnik, S, Banypersad, S, Fontana, M, Ntusi, N, Ferreira, V, Whelan, C, Myerson, S, Robson, M, Hawkins, P, Neubauer, S, Moon, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
ανά: Karamitsos, T, κ.ά.
Έκδοση: (2013)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.
ανά: Karamitsos, T, κ.ά.
Έκδοση: (2012)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
ανά: Karamitsos Theodoros, κ.ά.
Έκδοση: (2012-02-01)

Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
ανά: Sado, D, κ.ά.
Έκδοση: (2013)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
ανά: Dass, S, κ.ά.
Έκδοση: (2012)

Native T1 mapping in transthyretin amyloidosis
ανά: Fontana, M, κ.ά.
Έκδοση: (2014)

Native T1 mapping in transthyretin amyloidosis.
ανά: Fontana, M, κ.ά.
Έκδοση: (2014)

Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.
ανά: Sado, D, κ.ά.
Έκδοση: (2014)

Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
ανά: Dass, S, κ.ά.
Έκδοση: (2013)

Evaluation and management of the cardiac amyloidosis.
ανά: Selvanayagam, J, κ.ά.
Έκδοση: (2007)

Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping.
ανά: Ferreira, V, κ.ά.
Έκδοση: (2014)

Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping
ανά: Ferreira, V, κ.ά.
Έκδοση: (2014)

Erratum: Evaluation and management of the cardiac amyloidosis (Journal of the American College of Cardiology (2007) 50: (2101-2110))
ανά: Selvanayagam, J, κ.ά.
Έκδοση: (2011)

T1 Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T2-Weighted and late gadolinium enhanced imaging
ανά: Ferreira, V, κ.ά.
Έκδοση: (2013)

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
ανά: Ferreira, V, κ.ά.
Έκδοση: (2013)

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
ανά: Ntusi, N, κ.ά.
Έκδοση: (2014)

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - A clinical study using myocardial T1-mapping and extracellular volume quantification
ανά: Ntusi, N, κ.ά.
Έκδοση: (2014)

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
ανά: White, S, κ.ά.
Έκδοση: (2013)

T1 mapping for myocardial extracellular volume measurement by CMR: Bolus only versus primed infusion technique
ανά: White, S, κ.ά.
Έκδοση: (2013)

Is it really fat? Ask a T1-map.
ανά: Ferreira, V, κ.ά.
Έκδοση: (2013)

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
ανά: Fontana, M, κ.ά.
Έκδοση: (2012)

Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
ανά: Leeson, C, κ.ά.
Έκδοση: (2006)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
ανά: Dungu Jason, κ.ά.
Έκδοση: (2012-02-01)

Usefulness of Tc-99m-DPD scintigraphy in cardiac amyloidosis - Reply
ανά: Selvanayagam, J, κ.ά.
Έκδοση: (2008)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
ανά: Ferreira, V, κ.ά.
Έκδοση: (2014)

Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance.
ανά: Karamitsos, T, κ.ά.
Έκδοση: (2010)

THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING
ανά: Ferreira, V, κ.ά.
Έκδοση: (2013)

Novel Techniques for the Diagnosis of Acute Myocarditis: A Clinical Cardiovascular Magnetic Resonance Study
ανά: Ferreira, V, κ.ά.
Έκδοση: (2012)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents
ανά: Ferreira, V, κ.ά.
Έκδοση: (2014)

Cardiac Amyloidosis: Approach to Diagnosis
ανά: Neha Chopra, κ.ά.
Έκδοση: (2024-04-01)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
ανά: Rowin Ethan, κ.ά.
Έκδοση: (2013-01-01)

Role of noncontrast magnetic resonance pulmonary imaging in diagnosis of pulmonary embolism
ανά: Osama I Mohammad, κ.ά.
Έκδοση: (2022-01-01)

Human non-contrast T1 values and correlation with histology in diffuse fibrosis.
ανά: Bull, S, κ.ά.
Έκδοση: (2013)

Human non-contrast T1 values and correlation with histology in diffuse fibrosis
ανά: Bull, S, κ.ά.
Έκδοση: (2013)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
ανά: Dass, S, κ.ά.
Έκδοση: (2012)

Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities
ανά: Michele Orini, κ.ά.
Έκδοση: (2019-09-01)

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.
ανά: Dass, S, κ.ά.
Έκδοση: (2011)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
ανά: Faye A. Sharpley, κ.ά.
Έκδοση: (2020-05-01)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
ανά: Banypersad Sanjay M, κ.ά.
Έκδοση: (2013-01-01)

The Role of T2 Mapping in Cardiac Amyloidosis
ανά: Giulia Grazzini, κ.ά.
Έκδοση: (2024-05-01)